TARPLIN, DOWNS & YOUNG, LLC

Lobbying for NOVOCURE INC. · Oncology company with novel therapy for solid tumors

Filing 1st Quarter - Report

1st Quarter (Jan 1 - Mar 31) 2025 · Pennsylvania · House · Senate · $80,000.00 income · posted Apr 21, 2025

Lobbying activity 2

Medicare/Medicaid

Medicare coverage and reimbursement, national coverage determinations, skilled nursing facility bundled payment policy

Health Issues

FDA policies

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.